Enliven Therapeutics
ELVN
#5225
Rank
NZ$2.04 B
Marketcap
$41.90
Share price
-3.42%
Change (1 day)
121.29%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$0.28 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is NZ$0.28 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.52 M4.13%
2022-12-31NZ$0.5 M118.55%
2021-12-31NZ$0.23 M59.96%
2020-12-31NZ$0.14 M